EBS Financial Facts
Weighted-average number of shares - basic: 40.47MContracts and grants: 31.5M
See Full Income Statement
Other assets: 1.78M
Total assets: 932.03M
See Full Balance Sheet
Emergent BioSolutions, Inc. (EBS) Earnings
|
Expand Research on EBS
Next EPS Date | 5/1/24 | EPS Growth Rate | +73.8% |
---|---|---|---|
Average EPS % Beat Rate | -421.0% | Revenue Growth Rate | +12.3% |
Average % Move 1-Wk after EPS | -23.2% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/1/24 | Q124 | N/A | -$0.83 | N/A | N/A | $185.4M | N/A | N/A | N/A | ||
4/25/24 | Q124 | N/A | -$0.83 | N/A | N/A | $185.4M | N/A | N/A | N/A | ||
2/22/24 | Q423 | N/A | $0.16 | N/A | N/A | $282.16M | = | N/A | N/A | ||
3/6/24 | Q423 | N/A | $0.16 | N/A | N/A | $282.16M | = | N/A | N/A | ||
2/26/24 | Q423 | N/A | $0.16 | N/A | N/A | $282.16M | = | N/A | N/A | ||
11/2/23 | Q323 | N/A | -$0.28 | N/A | N/A | $237.43M | = | N/A | N/A | ||
11/8/23 | Q323 | N/A | $0.00 | N/A | $271M | $237.43M | = | N/A | N/A | ||
7/27/23 | Q223 | N/A | -$0.69 | N/A | N/A | $216.2M | = | N/A | N/A |